Symphony Environmental Technologies PLC shares shoot up 16% on impressive Covid

() shares shot up 16% in early trading after a highly successful coronavirus (COVID-19) test of antiviral gloves and masks containing the company’s d2pAM antimicrobial technology.

The assessment was carried out at the Laboratory of Virology at the University of Campinas, Brazil, and researchers looked at how effectively the protective equipment was able to combat the coronavirus strain MHV. This is the same genus and family as SARS-CoV-1, SARS-CoV-2/COVID-19 and MERS.

The results were impressive. The d2pAM glove showed a 99.99% virus-reduction after only one hour of contact. The d2pAM facemask showed a 99% virus-reduction after one hour of contact with the facemask, and 99.9% after two hours.

In a statement, Symphony chief executive, Michael Laurier said: “These test results are a significant step forward in our global marketing campaign to promote the importance of using our d2p technology in these everyday essential products.

“We believe this is a major breakthrough in the fight against COVID. These masks and gloves will provide essential additional protection for everyone, especially for staff, patients, and visitors in a hospital or care-home environment.”

At 8.15am, the shares were changing hands for 24.3p, up 3.4p.

— Adds share price —